about
Bevacizumab in Colorectal Cancer: Current Role in Treatment and the Potential of Biosimilars.CT-P13 in the treatment of rheumatoid arthritis.Update on Biosimilars in Asia.Translating New Science Into the Drug Review Process: The US FDA's Division of Applied Regulatory Science.Quality, Non-clinical and Clinical Considerations for Biosimilar Monoclonal Antibody Development: EU, WHO, USA, Canada, and BRICS-TM Regulatory GuidelinesIntegrating Biosimilars Into Oncology Practice: Implications for the Advanced PractitionerThe role of biosimilars in value-based oncology care
P2860
Q38643555-CD739CD3-464B-4D38-BBE0-39EA88788416Q38676104-0978C6F1-AEA8-4F5F-9309-0DFB7324F3FEQ39440987-FEF1D516-F8D5-4A9F-B70C-E7E1F890DDD7Q52641412-CD9E19E6-59B3-4DE7-A49C-214B4BAB9208Q58548075-86C28759-0EF1-42DE-8F10-89F773B2C6DAQ58585594-FE0AEF07-596F-4BDF-94D5-CBAD8E73A5EAQ58605622-B1268551-3E76-4513-9996-1B63239B2FBC
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Biosimilars: The US Regulatory Framework.
@en
Biosimilars: The US Regulatory Framework.
@nl
type
label
Biosimilars: The US Regulatory Framework.
@en
Biosimilars: The US Regulatory Framework.
@nl
prefLabel
Biosimilars: The US Regulatory Framework.
@en
Biosimilars: The US Regulatory Framework.
@nl
P2093
P1476
Biosimilars: The US Regulatory Framework.
@en
P2093
Janet Woodcock
Leah A Christl
Steven Kozlowski
P304
P356
10.1146/ANNUREV-MED-051215-031022
P577
2016-10-28T00:00:00Z